Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
The Launch Pad
Posted On: 08/24/2014 10:53:25 AM
Post# of 74549
Avatar
Posted By: Stock_Tracker
$JNJ Headlines

This one stock sector can withstand all the ‘bubble’ talk 6:00 a.m. Aug. 21, 2014 - Jeff Reeves
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
You don’t have to be a mega-mind to get this trade right 7:54 a.m. Aug. 6, 2014 - Jim Lowell
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
These eight health-care stocks could rise up to 75% 1:48 p.m. Aug. 5, 2014 - Philip van Doorn
J&J to call for voluntary return of morcellators 5:30 p.m. July 30, 2014 - MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’ 1:14 p.m. July 22, 2014 - MarketWatch
Johnson & Johnson sets $5 billion share buyback 5:20 p.m. July 21, 2014 - Jim Jelter
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. July 15, 2014 - Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92 7:50 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 sales up 9.1% to $19.5 billion 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 adjusted EPS $1.66 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 EPS $1.51 vs. $1.33 a year earlier 7:47 a.m. July 15, 2014 - William L. Watts
The market in a minute: Earnings over politics 10:56 a.m. July 14, 2014 - The Trading Deck


9 Dividend Aristocrats Reward Investors 6:19 a.m. Aug. 23, 2014 - Seeking Alpha
Join the Money Crowd 1:36 a.m. Aug. 23, 2014 - Barrons.com
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog 5:55 p.m. Aug. 22, 2014 - Zacks.com
Eli Lilly Uncovers Positive Data from Ixekizumab Studies - Analyst Blog 5:45 p.m. Aug. 22, 2014 - Zacks.com
Omnicom Offers Steady Profit Growth, Rising Dividend 4:25 p.m. Aug. 22, 2014 - Investors Business Daily
25 Dividend Champion Investment Opportunities: Something For Every Retired Investor, Part 1 6:27 p.m. Aug. 21, 2014 - Seeking Alpha
Apple Stock Held By Institutional Investors Rises 4:02 p.m. Aug. 21, 2014 - Investors Business Daily
Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going? 3:50 p.m. Aug. 21, 2014 - Seeking Alpha
3 Stocks Boosting The Drugs Industry Higher 1:03 p.m. Aug. 21, 2014 - TheStreet.com
Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow 11:00 a.m. Aug. 21, 2014 - TheStreet.com
The Bubble's Name Must Be Godot: We Keep Waiting And Waiting 10:22 a.m. Aug. 21, 2014 - Seeking Alpha
Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Boeing (BA) Lags 10:00 a.m. Aug. 21, 2014 - TheStreet.com
Ilumina collaborates with members of Big Pharma on molecular diagnostics 8:07 a.m. Aug. 21, 2014 - Seeking Alpha
Invest Wisely Or Prepare For Sticker Shock: A Message For All Parents 1:11 a.m. Aug. 21, 2014 - Seeking Alpha
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog 4:27 p.m. Aug. 20, 2014 - Zacks.com
GlaxoSmithKline: The Bad Isn't All That Bad 3:39 p.m. Aug. 20, 2014 - Seeking Alpha
High-Yield, High-Return Investments To Increase Income While Waiting On Dividend Growth 1:54 p.m. Aug. 20, 2014 - Seeking Alpha
4 Professions Vulnerable to Job-Killing Robots 5:36 a.m. Aug. 20, 2014 - InvestorPlace.com
Senators Want More Companies to Pull Surgical Device From Market 1:19 p.m. Aug. 19, 2014 - The Wall Street Journal Interactive Edition
3 Dividend ETFs for Income AND Growth 8:28 a.m. Aug. 19, 2014 - InvestorPlace.com


ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC. 9:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Global Anti-Aging Products Industry 11:46 a.m. Aug. 20, 2014 - PR Newswire - PRF
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck 9:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Stocks -- Teva Pharmaceutical Industries, AbbVie, Merck, Johnson and Johnson, and Bristol-Myers Squibb 9:10 a.m. Aug. 20, 2014 - PR Newswire - PRF
Abigail Honor is recognized by Continental Who's Who as a Pinnacle Professional 2:08 p.m. Aug. 19, 2014 - PR Newswire - PRF
Ophthalmic Devices Market Forecast 2014-2024: Future Prospects for Leading Companies 1:28 p.m. Aug. 19, 2014 - PR Newswire - PRF
Wearable Technology Ecosystem: 2014 - 2020 - Opportunities, Challenges, Strategies, Industry Verticals & Forecasts 1:04 p.m. Aug. 19, 2014 - PR Newswire - PRF
Manhattan Scientifics Reaches the Fork (Falk) in the Road 8:54 a.m. Aug. 19, 2014 - BusinessWire - BZX
Manhattan Scientifics Reaches the Fork (Falk) in the Road 8:40 a.m. Aug. 19, 2014 - BusinessWire - BZX
Dr. Jeffrey L. Sturchio Appointed President and Chief Executive Officer of Rabin Martin 8:47 a.m. Aug. 18, 2014 - PR Newswire - PRF
Lawsuit Settlement News Website Reports Update on Risperdal Litigation Due to Increase of Filed Cases 5:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Global Antiseptic and Disinfectant Products Market 2014-2018 11:21 a.m. Aug. 13, 2014 - PR Newswire - PRF
Can We Change the Culture of Youth Sports? 7:00 a.m. Aug. 13, 2014 - PR Newswire - PRF
Entia Biosciences' Supplements Could Prevent Dementia 9:55 a.m. Aug. 12, 2014 - ACCESSWIRE
David Defeats Goliath (Again), DECN and Pharma Tech Solutions Awarded Victory Over Johnson & Johnson Lifescan in USPTO Final Ruling 9:20 a.m. Aug. 11, 2014 - Marketwire
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 9:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Anapol Schwartz Law Firm Accepting Morcellation Cancer Cases 2:05 p.m. Aug. 8, 2014 - Marketwire
DePuy ASR Hip Settlement Funding Begins to Wind Down, Says Legal-Bay Lawsuit Funding 5:00 a.m. Aug. 7, 2014 - PR Newswire - PRF
Johnson & Johnson app makes it a snap to help students with United Way 9:45 a.m. Aug. 6, 2014 - PR Newswire - PRF
Drug Approvals and Earnings Releases - Research Reports on Bristol-Myers, Johnson & Johnson, Merck, Pharmacyclics and Amgen 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF


(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site